Heat and Exercise in Aging as Therapy (HEAT)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorTexas Tech University

About this trial

The main goal of this two-phase clinical trial is to learn whether local heat therapy, using heat pads applied to the legs, can enhance skeletal muscle health, physical function, and blood sugar control in a manner comparable to exercise, specifically High-Intensity Interval Training (HIIT), in older individuals with prediabetes. The study aims to answer the following questions:

1. Does local heat therapy improve muscle architecture (e.g., muscle cross-sectional area, capillary density, mitochondrial content), glucose tolerance, and frailty indicators similarly to HIIT in older individuals with prediabetes? 2. Does local heat therapy as a pre-conditioning method enhance the skeletal muscle response to HIIT in older individuals with prediabetes?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 50 years

Women who are postmenopausal, defined as no menstrual period for at least 12 consecutive months.

Sedentary (structured exercise <30 minutes, 3x/week)

Body weight is at least 110 lbs

Disqualifiers

History of peripheral neuropathies

Currently taking prescription blood thinners

Medical complications that could would contraindicate participation in the high intensity interval training (HIIT) intervention including: orthopedic complications that would limit your ability to perform cycling exercise, significant cardiovascular impairments (e.g., history of arrhythmias, severe uncontrolled hypertension, etc.), diagnosed metabolic disease (e.g., diabetes), renal disease, sickle cell anemia, or cancer in remission for <6 months.

Known history of slow wound healing

Trial design

Design model

Parallel

Treatments tested in this trial

  • Heat therapy

    Behavioral

    Heat pads will be set to a pre-determined, optimized temperature and applied to both legs for 90 min, 6d/wk (5 at-home and 1 in-lab).

  • High-intensity interval training

    Behavioral

    High-intensity interval training will be performed 3 days per week for 12 weeks.

Treatment groups

54 Participants
are divided into 3 treatment groups
Group A: Local Heat TherapyExperimental treatment 2 interventions
Group B: Thermoneutral TherapySham comparator 2 interventions
Group C: High-Intensity Interval TrainingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Glycemic control

Oral glucose tolerance test (OGTT)

Time frame
Before intervention, after Phase 1 (at about 12 weeks), and after Phase 2 (at about 24 weeks, except HIIT group)
2

Skeletal muscle architecture 1

Immunohistochemical assessment of muscle fiber cross-sectional area and capillary density

Time frame
Before intervention, after Phase 1 (at about 12 weeks), and after Phase 2 (at about 24 weeks, except HIIT group)
3

Skeletal muscle architecture 2

Assessment of skeletal muscle mitochondrial content

Time frame
Before intervention, after Phase 1 (at about 12 weeks), and after Phase 2 (at about 24 weeks, except HIIT group)
4

Frailty status

Fried's Phenotypic Frailty assessment

Time frame
Before intervention, after Phase 1 (at about 12 weeks), and after Phase 2 (at about 24 weeks, except HIIT group)

Secondary outcomes

1

Anthropometrics 1

Body mass and height to calculate body mass index (BMI)

Time frame
Weekly for about 14 (HIIT group) or about 27 (LHT and CON groups) weeks
2

Anthropometrics 2

Waist-to-hip ratio

Time frame
Weekly for about 14 (HIIT group) or about 27 (LHT and CON groups) weeks
3

Body composition

Lean versus fat mass assessed by dual-energy x-ray absorptiometry (DEXA)

Time frame
Before intervention, after Phase 1 (at about 12 weeks), and after Phase 2 (at about 24 weeks, except HIIT group)
4

Sleep quality

7-point likert scale

Time frame
Weekly for about 14 (HIIT group) or about 27 (LHT and CON groups) weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.